Atmaca, M. M. Et Al. 2012. Case of Dravet Syndrome Who Developed Acute Reversible Encephalopathy That May Have Been Caused by Hyperamonnemia Due to Pharmacokinetic Interaction Between Valproate and Stiripentol. EPILEPSI , vol.18, no.3 , 25-29.

Atmaca, M. M., Gurses, C., Marufoglu, F., BEBEK, N., BAYKAL, B., & Gokyigit, A., (2012). Case of Dravet Syndrome Who Developed Acute Reversible Encephalopathy That May Have Been Caused by Hyperamonnemia Due to Pharmacokinetic Interaction Between Valproate and Stiripentol. EPILEPSI , vol.18, no.3, 25-29.

Atmaca, Murat Et Al. "Case of Dravet Syndrome Who Developed Acute Reversible Encephalopathy That May Have Been Caused by Hyperamonnemia Due to Pharmacokinetic Interaction Between Valproate and Stiripentol," EPILEPSI , vol.18, no.3, 25-29, 2012

Atmaca, Murat M. Et Al. "Case of Dravet Syndrome Who Developed Acute Reversible Encephalopathy That May Have Been Caused by Hyperamonnemia Due to Pharmacokinetic Interaction Between Valproate and Stiripentol." EPILEPSI , vol.18, no.3, pp.25-29, 2012

Atmaca, M. M. Et Al. (2012) . "Case of Dravet Syndrome Who Developed Acute Reversible Encephalopathy That May Have Been Caused by Hyperamonnemia Due to Pharmacokinetic Interaction Between Valproate and Stiripentol." EPILEPSI , vol.18, no.3, pp.25-29.

@article{article, author={Murat Mert ATMACA Et Al. }, title={Case of Dravet Syndrome Who Developed Acute Reversible Encephalopathy That May Have Been Caused by Hyperamonnemia Due to Pharmacokinetic Interaction Between Valproate and Stiripentol}, journal={EPILEPSI}, year=2012, pages={25-29} }